|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.372 SEK | +0.54% |
|
-3.88% | -14.87% |
| Apr. 18 | Swedish Diagnostics Company AroCell Secures US Patent | MT |
| Feb. 22 | AroCell AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Redeye leaves its estimates and valuation untouched following the report. However, our gross margin assumptions might be reconsidered (downward) if the coming quarters do not show better gross margin development.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/
© Modular Finance, source
| 1st Jan change | Capi. | |
|---|---|---|
| -14.87% | 7.82M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
AROCELL AB 
